Continuation of pregnancy after first‐trimester exposure to mifepristone: an observational prospective study

Abstract

This first prospective study found that the rate of major malformations after first-trimester exposure to mifepristone is only slightly higher than the expected 2-3% rate in the general population. Such findings provide reassuring data for risk evaluation for continuation of pregnancy after mifepristone exposure.